Armata Pharmaceuticals Stock Forecast

Sell candidate since Jun 30, 2026 Loss -26.23%

The Armata Pharmaceuticals Inc. stock price gained 4.60% on the last trading day (Thursday, 30th Jul 2026), rising from $4.57 to $4.78. During the last trading day the stock fluctuated 10.89% from a day low at $4.50 to a day high of $4.99. The price has risen in 6 of the last 10 days and is up by 27.13% over the past 2 weeks. Volume fell on the last day by -32 thousand shares and in total, 64 thousand shares were bought and sold for approximately $306.25 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $5.23 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -50.00% during the next 3 months and, with a 90% probability hold a price between $1.45 and $2.61 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ARMP Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 16, 2026, and so far it has risen 27.13%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Armata Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.91 and $5.71. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Armata Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.51 and $4.26. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Armata Pharmaceuticals Inc. finds support just below today's level at $4.51. If this is broken, then the next support from accumulated volume will be at $4.26 and $3.76.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.490 between high and low, or 10.89%. For the last week the stock has had daily average volatility of 12.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARMP) For The Upcoming Trading Day Of Friday 31st

For the upcoming trading day on Friday, 31st we expect Armata Pharmaceuticals Inc. to open at $4.76, and during the day (based on 14 day Average True Range), to move between $4.48 and $5.08, which gives a possible trading interval of +/-$0.592 (+/-13.20%) up or down from last closing price. If Armata Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 13.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.83 (1.05%) than the support at $4.51 (5.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Armata Pharmaceuticals Inc. stock A Buy?

Armata Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.360 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 31, 2026 - $4.76 ( 0.488%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk